Clinical Trials in Miami

Showing 601-620 of 11,431 trials

Spinal Cord Injury Model Systems (SCIMS) - Education Module

NCT06003686

The purpose of this study is to find out if receiving education regarding increased risks of cardiometabolic disease helps subjects understand these risks and how these risks participants' health.

Spinal Cord InjuriesObesityCardiometabolic Syndrome

University of Miami250 participantsStarted Mar 2024

Washington D.C., District of Columbia, United States • Miami, Florida, United States • Dallas, Texas, United States

RECRUITINGNA< 1 mile

Non-invasive Glioma Characterization Through Molecular Imaging

NCT03684109

MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.

GliomaBrain TumorPrimary Brain Tumor+2 more

University of Miami30 participantsStarted Jan 2019

Miami, Florida, United States

COMPLETEDPhase 3< 1 mile

A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

NCT04083235

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxaliplatin compared to nab-paclitaxel + gemcitabine treatment in improving the overall survival of patients not previously treated for metastatic pancreatic cancer.

Metastatic Adenocarcinoma of the Pancreas

Ipsen770 participantsStarted Feb 2020

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Phoenix, Arizona, United States +197 more locations

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Non-invasive Glioma Characterization Through Molecular Imaging

A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Find Trials by Condition in Miami

Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects

Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Comparison of Uncomplicated Candidemia Therapy Duration in Children

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2